Floatz logo

L-Serine

Vaccine Adverse Reaction

Independent Medical AlliancePhase 2Active
CCC
49/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
34/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Vaccine Adverse Reaction cohort.

Same molecule, other indications

L-Serine is also rated in:

amyotrophic lateral sclerosisDormant
CCC
Indicative ·
53 / 100
View asset →
Post Acute Covid-19 Vaccination SyndromeDormant
CCC
Indicative ·
49 / 100
View asset →
Alzheimer diseaseDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →